Deutsche Bank
IDIX

Deutsche Bank’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

Deutsche Bank’s Portfolio IDIX Stock Details IDIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-89,580
Closed -$2.16M – 6396
2014
Q2 		$2.16M Buy
89,580
+8,286
+10% +$86.4K ﹤0.01% 2401
2014
Q1 		$490K Buy
81,294
+15,646
+24% +$109K ﹤0.01% 3346
2013
Q4 		$391K Sell
65,648
-86,317
-57% -$399K ﹤0.01% 3283
2013
Q3 		$787K Sell
151,965
-137,893
-48% -$604K ﹤0.01% 3158
2013
Q2 		$1.04M Buy
+289,858
New +$1.19M ﹤0.01% 2660

Deutsche Bank's IDIX Position: Q3 2014 in Review

Deutsche Bank sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 89,580 shares — an estimated $2.16M sold.

Deutsche Bank first reported a position in IDIX in Q2 2013 and held it in 5 quarters. The position peaked at $2.16M in Q2 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

  • Deutsche Bank reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • Deutsche Bank sold 89,580 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $2.16M.
  • Deutsche Bank first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2013 and held it in 5 quarters.
  • Deutsche Bank's IDENIX PHARMACEUTICALS INC position peaked at $2.16M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on Deutsche Bank's 13F filing for Q3 2014, filed 14 Nov 2014.